Importance of digital health in patient management of Parkinson's disease

doi:10.3969/j.issn.1672-6731.2022.03.001

Abstract

Abstract: With the continuous iteration of technological innovation, the medical and health industry ushered in a new stage of digital health development. This article expounds the connotation and application of digital health, and discusses the development, advantages and disadvantages of digital health in the management of patients with Parkinson's disease (PD), so as to utilize digital health to pave the way for improving the whole-disease-cycle management of patients with PD, and to lay the foundation for improving their health and well-being and realizing Healthy China in an all-round way.

Key words: Parkinson disease, Delivery of health care, Digital health (not in MeSH)

摘要： 随着技术创新的不断迭代，医疗健康迎来数字医疗发展的新阶段。本文阐述数字医疗的内涵与应用，探讨数字医疗在帕金森病患者管理中的进展、优势与不足，以期引导数字医疗为完善帕金森病患者全程管理体系搭桥铺路，为提高患者生活质量、全面实现健康中国奠定基础。

关键词: 帕金森病, 卫生保健提供, 数字医疗(非MeSH词)

CHAN Piu, ZHANG Qi-hao. Importance of digital health in patient management of Parkinson's disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2022, 22(3): 127-130.

陈彪, 张齐皓. 应重视数字医疗在帕金森病患者管理中的作用[J]. 中国现代神经疾病杂志, 2022, 22(3): 127-130.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2022.03.001

https://journal11.magtechjournal.com/cjcnn/EN/Y2022/V22/I3/127

References

[1] Global strategy on digital health 2020-2025[DB/OL]. Geneva:World Health Organization, 2021[2022-03-12]. https://apps.who.int/iris/bitstream/handle/10665/344249/9789240020924-eng.pdf
[2] Digital Health Center of Excellence[DB/OL]. Washington:U.S.S. Food & Drug Administration, 2022[2022-03-12]. https://www.fda.gov/medical-devices/digital-health-center-excellence
[3] Fatehi F, Samadbeik M, Kazemi A. What is digital health:review of definitions[J]? Stud Health Technol Inform, 2020, 275:67-71.
[4] Xue P, Bai AY, Jiang Y, Qiao YL. WHO global strategy on digital health and its implications to China[J]. Zhonghua Yu Fang Yi Xue Za Zhi, 2022, 56:218-221.[薛鹏, 白安颖, 江宇,乔友林. WHO数字健康全球战略及对中国的启示[J]. 中华预防医学杂志, 2022, 56:218-221.]
[5] Liu SY, Chan P. Epidemiology of Parkinson's disease[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2016, 16:98-101.[刘疏影, 陈彪. 帕金森病流行现状[J]. 中国现代神经疾病杂志, 2016, 16:98-101.]
[6] Parkinson's Disease and Movement Disorders Group, Neurologist Branch, Chinese Medial Association; Committee of Parkinson's Disease and Dyskinesia, Neurologist Branch, Chinese Medical Doctor Association. Chinese expert consensus on research criteria for prodromal Parkinson's disease[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2019, 38:825-831.[中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍病专业委员会. 帕金森病前驱期诊断研究标准中国专家共识[J]. 中华老年医学杂志, 2019, 38:825-831.]
[7] Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson's disease[J]. Parkinsonism Relat Disord, 2010, 16:79-84.
[8] Riggare S, Stamford J, Hägglund M. A long way to go:patient perspectives on digital health for Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S5-10.
[9] Mirelman A, Dorsey ER, Brundin P, Bloem BR. Using technology to reshape clinical care and research in Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S1-3.
[10] Klucken J, Krüger R, Schmidt P, Bloem BR. Management of Parkinson's disease 20 years from now:towards digital health pathways[J]. J Parkinsons Dis, 2018, 8(s1):S85-94.
[11] Healthy China Action Promotion Committee. Healthy China Action (2019-2030):overall requirements, major actions and key indicators[J]. Zhongguo Xun Huan Za Zhi, 2019, 34:846-858.[健康中国行动推进委员会. 健康中国行动(2019-2030年):总体要求、重大行动及主要指标[J]. 中国循环杂志, 2019, 34:846-858.]
[12] Dorsey ER, Okun MS, Bloem BR. Care, convenience, comfort, confidentiality, and contagion:the 5 C's that will shape the future of telemedicine[J]. J Parkinsons Dis, 2020, 10:893-897.
[13] Hanein Y, Mirelman A. The home-based sleep laboratory[J]. J Parkinsons Dis, 2021, 11(s1):S71-76.
[14] Sacks L, Kunkoski E. Digital health technology to measure drug efficacy in clinical trials for Parkinson's disease:a regulatory perspective[J]. J Parkinsons Dis, 2021, 11(s1):S111-115.
[15] Del Din S, Kirk C, Yarnall AJ, Rochester L, Hausdorff JM. Body-worn sensors for remote monitoring of Parkinson's disease motor symptoms:vision, state of the art, and challenges ahead[J]. J Parkinsons Dis, 2021, 11(s1):S35-47.
[16] Simonet C, Noyce AJ. Domotics, smart homes, and Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S55-63.
[17] Number of smartphone subscriptions worldwide from 2016 to 2027[DB/OL]. Telecommunications, 2022[2022-03-12]. https://www.www.statista.com/statistics/330695/number-of-smartphone-users-worldwide/
[18] Little MA. Smartphones for remote symptom monitoring of Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S49-53.
[19] Shalash A, Spindler M, Cubo E. Global perspective on telemedicine for Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S11-18.
[20] Ellis TD, Earhart GM. Digital therapeutics in Parkinson's disease:practical applications and future potential[J]. J Parkinsons Dis, 2021, 11(s1):S95-101.
[21] Christie RH, Abbas A, Koesmahargyo V. Technology for measuring and monitoring treatment compliance remotely[J]. J Parkinsons Dis, 2021, 11(s1):S77-81.
[22] Theodoros D. Telerehabilitation for communication and swallowing disorders in Parkinson's disease[J]. J Parkinsons Dis, 2021, 11(s1):S65-70.
[23] Dobkin RD, Interian A, Durland JL, Gara MA, Menza MA. Personalized telemedicine for depression in Parkinson's disease:a pilot trial[J]. J Geriatr Psychiatry Neurol, 2018, 31:171-176.
[24] Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, Wang ZF, Zhang X, Zhu JH. Prevalence of Alzheimer's disease and Parkinson's disease in China:an updated systematical analysis[J]. Front Aging Neurosci, 2020, 12:603854.
[25] Zhou XF, Chen L. Digital health care in China and access for older people[J]. Lancet Public Health, 2021, 6:e873-874.

Please choose a citation manager

Content to export